🔬Last September 24th was #WorldCancerResearchDay and we wanted to honor the power of research to transform cancer care. At #RENACER, we promote research as it is the basis for developing earlier diagnoses, personalising treatments and bringing hope to patients with brain metastases.

🆕 The AEMPS offers a monthly newsletter on oncology regulation. If you are a patient, a professional, or a researcher, stay informed of changes shaping the future of cancer by subscribing here: gob.us4.list-manage.com/subscribe?u=...

📋At #RENACER, we know biobanks can transform health care —but only with strong legal frameworks. A study reviews Spain’s biobank laws, their strengths and limitations, and how to enhance their impact. 📖 Read the full article: doi.org/10.1089/bio....

🧠 Save the Date! 📅 24 Oct 2025 | 🕥 10:30–15:00 📍 Fundación Ramón Areces, Madrid Join the 5th RENACER GA to share breakthroughs in #BrainMetastasis. Talks by top experts on CNS mets, lung cancer & more. 🔗 Register: bit.ly/3U4ROA3 #Oncology #RENACER

🧠 New research reveals why #Immunotherapy often fails in symptomatic #BrainMetastases: some astrocytes block T-cell activity. By combining treatments, this local immunosuppression is no longer observed. A promising step towards personalized treatment! bit.ly/3IvfqLw

“Driving research forward isn’t just about starting projects; it’s about supporting them all the way through. In the case of RENACER, this ensures that no tumour is left behind. 🗣️Dr Niebla Priego, a postdoctoral researcher in the Brain Metastasis Group at CNIO.

The International Agency for Research on Cancer (WHO) and American Cancer Society have launched the 4th edition of the Cancer Atlas, a free tool with global data on cancer trends, risks & prevention. 🌍📊 🔗 canceratlas.cancer.org

Dr Manuel Vailente & Dr Benedicto Crespo-Facorro reflect on the brain, cancer, & the need of collaboration. From brain metastasis to science communication, they call for research with real impact. #WorldBrainDay 🔗 Full interview:

🧠 Brain metastases affect up to 30% of cancer patients. Yet key aspects remain poorly understood. MoLab's new review in Mathematical Biosciences explores how mathematical models can predict tumour growth & treatment response. 🔗 sciencedirect.com/science/arti...

The 5th RENACER General Assembly will connect professionals, researchers & all those interested in brain metastasis to learn about the new advances that are being developed in this field. 📅 Friday, Oct 24th 📍 Ramón Areces Foundation, Madrid 🕥 10:30 - 15:00 h

At #RENACER, we support research that brings us closer to personalised treatments. This study led by Zhu et al. uses organotypic cultures to identify vulnerabilities in brain metastases. A major step forward!​ 🔗 pubmed.ncbi.nlm.nih.gov/35174975/

The 2025 EACR Congress is the key meeting for cancer researchers tackling brain metastases. Topics like tumour evolution & immune evasion are vital for advancing personalised medicine. RENACER is proud to connect teams driving this progress. 🧬 🔗 2025.eacr.org

We are very excited to share this article from focused on our work to treat brain metastasis. With the participation of patients, professionals, and project leaders, the article highlights the challenges of treating this disease and the progress being made.​ www.elmundo.es/ciencia-y-sa...

This year’s #NMNSymposium spotlighted key advances in #neurooncology: from single-cell tech to AI imaging and immunotherapy. Topics that resonate deeply with our work at #RENACER.​ 🔗 www.nmn-society.org/program/%E2%...

🧠 At #ASCO2025, Dr Juan Manuel Sepúlveda (Hospital 12 de Octubre & #RENACER) presented early results from the CAN-201 NDG trial testing azeliragon + standard care in glioblastoma. 📄 ascopubs.org/doi/pdf/10.1... #NeuroOncology #ClinicalResearch #TranslationalMedicine

Today on #ClinicalTrialsDay, we highlight their key role in advancing medicine. At #RENACER, we’re building the knowledge needed for future trials in brain metastases, a cancer complication still lacking effective treatments. 🧠

Brain metastases are major challengein oncology. At RENACER, we are changing this with a unique workflow to collect, analyse, and classify them. Our approachdrives better treatmentsand outcomes. Discovermore in ournew infographic! 🔗 renacerbrainmet.org/renacer/

We welcome @hospitaldelmar.bsky.social and Hospital Clínico Universitario de Santiago to our growing network! 🏥🧠​ With 21 hospitals across Spain, RENACER brings together clinical experts to drive research into brain metastases and improve patient care.​ 🔗 renacerbrainmet.org/es/miembros-...

🧬 On #InternationalDNADay, we highlight a key challenge in oncology: the genetic diversity of tumours. At RENACER, we are working to turn these discoveries into personalised therapies.​ Read more 👉 pubmed.ncbi.nlm.nih.gov/35120664/

Research is the foundation of a healthier future. 🔬 That’s why we are working to advance the next generation of personalised medicine for brain metastases. Learn more about our research with @valientelab! 👇 🔗 www.youtube.com/embed/1IGtva... #WorldHealthDay

📊✨ En el #DíaInternacionalDeLasMatemáticas destacamos cómo los modelos matemáticos pueden predecir la recurrencia de metástasis cerebrales tras radioterapia. Un estudio de @molab_uclm abre la puerta a tratamientos más personalizados. ​ 📖 Lee más aquí:

En la #SemanaDelCerebro reforzamos nuestro compromiso para afrontar las metástasis cerebrales de manera multidisciplinar, avanzando hacia tratamientos más efectivos y menos agresivos para mejorar la vida de los pacientes.🧠💙​ #MetástasisCerebrales #InvestigaciónOncológica

📢 El II Encuentro de Investigadores Contra el Cáncer de @ContraCancerEs reúne expertos de toda España para impulsar la innovación en oncología. ¡Nuestro compañero Víctor Pérez de @molab_uclm estará allí! ¿Nos vemos? ​ 📅 4 de marzo | 📍 Madrid ​ Más info 👉

🧠✨ ¡Vuelve la newsletter de RENACER! ​ Descubre los últimos avances en la investigación de metástasis cerebrales: nuevas estrategias terapéuticas, proyectos innovadores y reconocimientos a nuestra labor científica. 📩 ​ 🔗 https://buff.ly/4gFKvYk

Drs. @NeiblaPriego & @valientelab's work on brain metastasis has been recognised by @ContraCancerEs as top 4 studies of the year! 🎉 They have discovered how neurons interacting with the immune system fuels metastasis. 🧠💉 ​ Read the full paper 👉 https://buff.ly/40IL11P​

Support between projects drives scientific progress! 🎉 Congrats to @eu_nanobright & Dr. @ManuelValiente on developing a minimally invasive technique to improve brain metastasis diagnosis & treatment. 💡​ We're excited to see progress towards more treatments for brain tumours. 🧠

🔬 New research by @valientelab.bsky.social et al., published in Cancer Discovery, reveals how #brainmetastases adapt to evade targeted therapies. These findings point to molecular vulnerabilities that could help overcome therapeutic resistance.

How do nerves influence cancer? 🔬The field of cancer neuroscience explores their role in cancer initiation & progression—offering new insights for cancers outside the brain & spinal cord. Read more in this paper co-authored by our very own @valientelab.bsky.social

🚀 The project ALTER-BRAIN from @valientelab.bsky.social is decoding molecular patterns in #brainmetastases! Funded by an ERC grant, it explores how the metastatic microenvironment is reprogrammed to develop prevention and treatment strategies. Stay tuned for groundbreaking #cancerresearch updates!

Manuel Valiente from @valientelab.bsky.social was recently interviewed in @elmundo.es.web.brid.gy! He discussed key advances in brain metastases research, focusing on how cancer adapts in the brain and strategies to overcome resistance. 👉 www.elmundo.es/ciencia-y-sa...